Innsun Roh

Background

About Innsun Roh

I joined EXOSYSTEMS because our CEO, Hooman Lee, painted a clear and compelling vision: harness technology-driven rehabilitation to measurably improve quality of life for people living with neurological conditions. Coming from an engineering background, I saw a rare chance to bridge deep tech with everyday clinical reality—turning data into movement, confidence, and independence for patients who need it most. We solve a critical gap in neuro care by providing quantitative, objective neuromuscular disease diagnostics. Our proprietary AI motor-function assessment, paired with wearable sensors, gives frontline medical professionals precise insights and equips global pharmaceutical teams with validated digital endpoints that de-risk clinical development. In the U.S, we deliver FDA-registered, prescription-based, at-home exercise programs in the form of remote therapeutic monitoring (RTM) for the U.S. patients in need of neuromuscular care so clinicians can follow their progress—and bill for that care—between visits. My long-term vision is to standardize our AI-driven neuromuscular digital biomarkers—spanning RTM, diagnosis, and therapy optimization—across the full patient journey. When every clinician can act on robust, real-time data, we’ll shorten time-to-treatment, individualize interventions, and ultimately elevate outcomes for millions. If you’re a medical professional or part of a pharmaceutical clinical-development team interested in redefining how we understand and treat neurological diseases through advanced digital biomarkers, let’s connect. I’m keen to collaborate with partners who share our passion for evidence-based innovation in musculoskeletal and neuromuscular disease diagnosis and rehabilitation.